Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial.

[1]  C. Zoccali,et al.  Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease , 2002, Circulation.

[2]  W. Bloembergen,et al.  A cross-sectional study of the prevalence and clinical correlates of congestive heart failure among incident US dialysis patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  P. Russo,et al.  Dilated cardiomyopathy in dialysis patients--beneficial effects of carvedilol: a double-blind, placebo-controlled trial. , 2001, Journal of the American College of Cardiology.

[4]  P. Raggi.  Imaging of cardiovascular calcifications with electron beam tomography in hemodialysis patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[5]  L. Gesualdo,et al.  Clinical relevance of cytokine production in hemodialysis. , 2000, Kidney international. Supplement.

[6]  A. Iacono,et al.  Efficacy of carvedilol on complex ventricular arrhythmias in dilated cardiomyopathy: double-blind, randomized, placebo-controlled study. , 2000, European heart journal.

[7]  R. Elashoff,et al.  Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. , 2000, The New England journal of medicine.

[8]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[9]  D. Sica,et al.  The pharmacokinetics of carvedilol and its metabolites after single and multiple dose oral administration in patients with hypertension and renal insufficiency , 1999, European Journal of Clinical Pharmacology.

[10]  G. Remuzzi.  Sympathetic overactivity in hypertensive patients with chronic renal disease. , 1999, The New England journal of medicine.

[11]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[12]  F. Locatelli,et al.  Morbidity and Mortality on Maintenance Haemodialysis , 1998, Nephron.

[13]  R. Luke.  Chronic renal failure--a vasculopathic state. , 1998, The New England journal of medicine.

[14]  A. Iacono,et al.  [Complex ventricular arrhythmias and carvedilol: efficacy in hemodialyzed uremic patients]. , 1998, Cardiologia.

[15]  S. Kariuki.  Kenya: antibiotic resistance , 1997, The Lancet.

[16]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[17]  G. Feuerstein,et al.  Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection. , 1996, European heart journal.

[18]  F. Berthoux,et al.  End stage renal disease and dialysis report , 1996 .

[19]  F. Berthoux,et al.  Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The EDTA-ERA Registry. European Dialysis and Transplant Association-European Renal Association. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  David C. Murray,et al.  Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. , 1995, Kidney international.

[21]  F. Valderrábano,et al.  Report on management of renal failure in Europe, XXIV, 1993. , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[22]  J. Ehrich,et al.  Report on management of renal failure in Europe, XXIII. , 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[23]  R. Converse,et al.  Sympathetic overactivity in patients with chronic renal failure. , 1992, The New England journal of medicine.

[24]  E. F. Smith,et al.  Myocardial protection with carvedilol. , 1992, Journal of cardiovascular pharmacology.

[25]  M. H. Gault,et al.  Congestive heart failure in dialysis patients. , 1988, Archives of internal medicine.

[26]  D. Andresen,et al.  Complex ventricular arrhythmias. , 1981, Circulation.